ArticlebioRxiv : the preprint server for biology2025
Targeting tumor-intrinsic TAK1 triggers anti-tumor immunity and sensitizes pancreatic cancer to checkpoint blockade.
Sapana P Bansod et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.